院士论坛

心血管受体的信号转导与疾病

  • 董尔丹
展开
董尔丹,中国工程院院士,北京大学博雅讲席教授,北京大学心血管研究所所长,分子心血管学教育部重点实验室主任,北京大学第三医院血管医学研究所研究员。任中国医学科学院学部委员,中国中医科学院学部委员,教育部科学技术委员会科技伦理专门委员会主任委员,中国科协学会与学术委员会委员,中国病理生理学会副理事长,国际心脏研究会中国分会副主席,中华医学会医学科研管理专业委员会候任主任委员等。任Science China Life SciencesChinese Medical Journal、中华心血管病杂志等学术期刊主编或编委。
长期从事心血管基础研究和医学科技管理工作。发现心脏β肾上腺素受体分布及病理变化并阐明其减敏机制,发现血管α1肾上腺素受体亚型分布、功能特点及其信号转导机制,为心血管功能调控提供理论依据。“从无到有”构建以人体器官/系统为基础,以科学问题为导向,以疾病发生发展转归为核心的国家科学基金医学体系。以“结构-过程-绩效”理念推进创新管理实践,围绕国家重大需求和科学前沿,实施战略规划和统筹布局,“从有到优”促进我国医学学科发展、人才成长、自主创新、开放合作。主持多项国家级课题,发表论文170余篇。获何梁何利基金科学与技术进步奖、中华医学科研管理杰出贡献奖,享受国务院政府特殊津贴

收稿日期: 2022-06-14

  网络出版日期: 2022-10-14

本文引用格式

董尔丹 . 心血管受体的信号转导与疾病[J]. 北京大学学报(医学版), 2022 , 54(5) : 796 -802 . DOI: 10.19723/j.issn.1671-167X.2022.05.003

参考文献

1 Dale HH . On some physiological actions of ergot[J]. J Physiol, 1906, 34 (3): 163- 206.
2 Ahlquist RP . A study of the adrenotropic receptors[J]. Am J Physiol, 1948, 153 (3): 586- 600.
3 Lands AM , Luduena FP , Buzzo HJ . Differentiation of receptors responsive to isoproterenol[J]. Life Sci, 1967, 6 (21): 2241- 2249.
4 Langer SZ . Presynaptic regulation of catecholamine release[J]. Biochem Pharmacol, 1974, 23 (13): 1793- 1800.
5 Han C , Abel PW , Minneman KP . Heterogeneity of alpha 1-adrenergic receptors revealed by chlorethylclonidine[J]. Mol Pharmacol, 1987, 32 (4): 505- 510.
6 James B . Pioneers in cardiology: Sir James Black, MB, ChB, FRS, FRCP. Interview by Mark Nicholls[J]. Circulation, 2008, 117 (8): f47- f48.
7 Cerione RA , Strulovici B , Benovic JL , et al. Pure beta-adrenergic receptor: The single polypeptide confers catecholamine responsiveness to adenylate cyclase[J]. Nature, 1983, 306 (5943): 562- 566.
8 Nguyen AH , Thomsen A , Cahill TR , et al. Structure of an endosomal signaling GPCR-G protein-beta-arrestin megacomplex[J]. Nat Struct Mol Biol, 2019, 26 (12): 1123- 1131.
9 Page IH , Helmer OM . A crystalline pressor substance (angiotonin) resulting from the reaction between renin and renin-activator[J]. J Exp Med, 1940, 71 (1): 29- 42.
10 Lin SY , Goodfriend TL . Angiotensin receptors[J]. Am J Physiol, 1970, 218 (5): 1319- 1328.
11 Whitebread S , Mele M , Kamber B , et al. Preliminary biochemical characterization of two angiotensin Ⅱ receptor subtypes[J]. Biochem Biophys Res Commun, 1989, 163 (1): 284- 291.
12 Xiao RP , Zhang SJ , Chakir K , et al. Enhanced G(i) signaling selectively negates beta2-adrenergic receptor (AR), but not beta1-AR-mediated positive inotropic effect in myocytes from failing rat hearts[J]. Circulation, 2003, 108 (13): 1633- 1639.
13 Noma T , Lemaire A , Naga PS , et al. Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection[J]. J Clin Invest, 2007, 117 (9): 2445- 2458.
14 Li Y , Zhang H , Liao W , et al. Transactivated EGFR mediates α1-AR-induced STAT3 activation and cardiac hypertrophy[J]. Am J Physiol Heart Circ Physiol, 2011, 301 (5): H1941- H1951.
15 Liu F , He K , Yang X , et al. α1A-adrenergic receptor induces activation of extracellular signal-regulated kinase 1/2 through endocytic pathway[J]. PLoS One, 2011, 6 (6): e21520.
16 Wang W , Bian J , Li Z . Internalized activation of membrane receptors: From phenomenon to theory[J]. Trends Cell Biol, 2021, 31 (6): 428- 431.
17 Wang W , Qiao Y , Li Z . New insights into modes of GPCR activation[J]. Trends Pharmacol Sci, 2018, 39 (4): 367- 386.
18 Liang N , Bing Z , Wang Y , et al. Clinical implications of EGFR-associated MAPK/ERK pathway in multiple primary lung cancer[J]. Clin Transl Med, 2022, 12 (5): e847.
19 Zaryouh H , De Pauw I , Baysal H , et al. Recent insights in the PI3K/Akt pathway as a promising therapeutic target in combination with EGFR-targeting agents to treat head and neck squamous cell carcinoma[J]. Med Res Rev, 2022, 42 (1): 112- 155.
20 Andl CD , Mizushima T , Oyama K , et al. EGFR-induced cell migration is mediated predominantly by the JAK-STAT pathway in primary esopha-geal keratinocytes[J]. Am J Physiol Gastrointest Liver Physiol, 2004, 287 (6): G1227- G1237.
21 Wang J , Ma J , Nie H , et al. Hepatic regulator of G protein signaling 5 ameliorates nonalcoholic fatty liver disease by suppressing transforming growth factor beta-activated kinase 1-c-Jun-N-terminal kinase/p38 signaling[J]. Hepatology, 2021, 73 (1): 104- 125.
22 Grimm M , Brown JH . Beta-adrenergic receptor signaling in the heart: Role of CaMKⅡ[J]. J Mol Cell Cardiol, 2010, 48 (2): 322- 330.
23 Xiao H , Li H , Wang JJ , et al. IL-18 cleavage triggers cardiac inflammation and fibrosis upon β-adrenergic insult[J]. Eur Heart J, 2018, 39 (1): 60- 69.
24 尹峰, 吕志珍, 韩启德, 等. β2-肾上腺素受体在新生大鼠心肌成纤维细胞中的分布及其促增殖作用[J]. 生理学报, 2003, 55 (3): 251- 254.
25 Schnee JM , Hsueh WA . Angiotensin Ⅱ, adhesion, and cardiac fibrosis[J]. Cardiovasc Res, 2000, 46 (2): 264- 268.
26 Xiao H , Ma X , Feng W , et al. Metformin attenuates cardiac fibrosis by inhibiting the TGFβ1-Smad3 signalling pathway[J]. Cardiovasc Res, 2010, 87 (3): 504- 513.
27 Lim GB . Sustained BP reduction with renal denervation[J]. Nat Rev Cardiol, 2022, 19 (6): 352.
28 Ruiz-Ortega M , Lorenzo O , Rupérez M , et al. Angiotensin Ⅱactivates nuclear transcription factor κB through AT1 and AT2 in vascular smooth muscle cells: molecular mechanisms[J]. Circ Res, 2000, 86 (12): 1266- 1272.
29 Verweij P , Danaietash P , Flamion B , et al. Randomized dose-response study of the new dual endothelin receptor antagonist aprocitentan in hypertension[J]. Hypertension, 2020, 75 (4): 956- 965.
30 Kong P , Cui ZY , Huang XF , et al. Inflammation and atherosclerosis: Signaling pathways and therapeutic intervention[J]. Signal Transduct Target Ther, 2022, 7 (1): 131.
31 Robbins CS , Chudnovskiy A , Rauch PJ , et al. Extramedullary hematopoiesis generates Ly-6Chigh monocytes that infiltrate atherosclerotic lesions[J]. Circulation, 2012, 125 (2): 364- 374.
32 Hinterdobler J , Schott S , Jin H , et al. Acute mental stress drives vascular inflammation and promotes plaque destabilization in mouse atherosclerosis[J]. Eur Heart J, 2021, 42 (39): 4077- 4088.
33 Han C , Liu J , Liu X , et al. Angiotensin Ⅱ induces C-reactive protein expression through ERK1/2 and JNK signaling in human aortic endothelial cells[J]. Atherosclerosis, 2010, 212 (1): 206- 212.
34 Li M , Liu J , Han C , et al. Angiotensin Ⅱ induces the expression of C-reactive protein via MAPK-dependent signal pathway in U937 macrophages[J]. Cell Physiol Biochem, 2011, 27 (1): 63- 70.
35 Xu L , Liu JT , Li K , et al. Genistein inhibits Ang Ⅱ-induced CRP and MMP-9 generations via the ER-p38/ERK1/2-PPARγ-NF-κB signaling pathway in rat vascular smooth muscle cells[J]. Life Sci, 2019, 216, 140- 146.
36 Ridker PM , Rane M . Interleukin-6 signaling and anti-interleukin-6 therapeutics in cardiovascular disease[J]. Circ Res, 2021, 128 (11): 1728- 1746.
37 Geraghty L , Santangeli P , Tedrow UB , et al. Contemporary management of electrical storm[J]. Heart Lung Circ, 2019, 28 (1): 123- 133.
文章导航

/